Evidence map›Paper›PMID 40301594›Full record

ArticleScientific reports2025

CD8α marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potential.

Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbara Rosati, David Carlson, Nai-Kong V Cheung, Hong Xu, James Bean, Katharine C Hsu and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nezar Mehanna *Renaissance School of Medicine at Stony Brook University, 101 Nicolls Road, Health Sciences Center 15060-I, Stony Brook, NY, 11794, USA.
Atul Pradhan *Renaissance School of Medicine at Stony Brook University, 101 Nicolls Road, Health Sciences Center 15060-I, Stony Brook, NY, 11794, USA.
Rimanpreet Kaur *Renaissance School of Medicine at Stony Brook University, 101 Nicolls Road, Health Sciences Center 15060-I, Stony Brook, NY, 11794, USA.
Theodota KontopoulosHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Barbara RosatiRenaissance School of Medicine at Stony Brook University, 101 Nicolls Road, Health Sciences Center 15060-I, Stony Brook, NY, 11794, USA.
David CarlsonRenaissance School of Medicine at Stony Brook University, 101 Nicolls Road, Health Sciences Center 15060-I, Stony Brook, NY, 11794, USA.
Nai-Kong V CheungDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Hong XuDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
James BeanImmunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Katharine C HsuHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Jean-Benoit Le Luduec *Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Charles Kyriakos Vorkas *Renaissance School of Medicine at Stony Brook University, 101 Nicolls Road, Health Sciences Center 15060-I, Stony Brook, NY, 11794, USA. charles.vorkas@stonybrookmedicine.edu.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
The role of Mucosal-associated invariant T (MAIT) cells during the innate immune response to Mycobacterium tuberculosisK08AI132739 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI VORKAS, CHARLES KYRIAKOS · 2018 to 2022
$921k
Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.R21AI171578 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI VORKAS, CHARLES KYRIAKOS · 2023 to 2024
$468k
National Institute of Allergy and Infectious Diseases K08AI132739NCI NIH HHS P30 CA008748NIAID NIH HHS K08 AI132739NIAID NIH HHS R21 AI171578TRBU Network U19 AI11143
6 · The paper itself

Abstract

Natural Killer (NK) cells can recognize and kill Mycobacterium tuberculosis (Mtb)-infected cells in vitro, however their role after natural human exposure has not been well-studied. To identify Mtb-responsive NK cell populations, we analyzed the peripheral blood of healthy household contacts of active Tuberculosis (TB) cases and source community donors in an endemic region of Port-au-Prince, Haiti by flow cytometry. We observed higher CD8α expression on NK cells in putative resistors (Interferon γ release assay negative; IGRA- contacts) with a loss of CD8α surface expression during household-associated exposure and active TB disease. In vitro assays and CITE-seq analysis of CD8α

Indexed as

CD8 AntigensKiller Cells, NaturalLymphocyte ActivationMycobacterium tuberculosisTuberculosisAdultFemaleHumansMaleCD8 Antigens

Identifiers

PMID40301594
PMCPMC12041513

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.